TWI750142B - Dentifrices - Google Patents

Dentifrices Download PDF

Info

Publication number
TWI750142B
TWI750142B TW105139492A TW105139492A TWI750142B TW I750142 B TWI750142 B TW I750142B TW 105139492 A TW105139492 A TW 105139492A TW 105139492 A TW105139492 A TW 105139492A TW I750142 B TWI750142 B TW I750142B
Authority
TW
Taiwan
Prior art keywords
mass
oral composition
dentifrice
scutellaria baicalensis
acid
Prior art date
Application number
TW105139492A
Other languages
Chinese (zh)
Other versions
TW201800087A (en
Inventor
稻垣瑞希
坪川理美
Original Assignee
日商日本澤托克股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商日本澤托克股份有限公司 filed Critical 日商日本澤托克股份有限公司
Publication of TW201800087A publication Critical patent/TW201800087A/en
Application granted granted Critical
Publication of TWI750142B publication Critical patent/TWI750142B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/076Poria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539Scutellaria (skullcap)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

An oral composition is provided in the present invention. The oral composition contains scutellaria root, cinnamon bark and poria sclerotium. In the oral composition, when an amount of the scutellaria root is defined as XA [mass%] and an amount of the cinnamon bark is defined as XB [mass%], it is preferred that the following relation is satisfied: 0.00005
Figure 105139492-A0305-02-0001-3
XB/XA
Figure 105139492-A0305-02-0001-4
20000. In the oral composition, when the amount of the scutellaria root is defined as XA [mass%] and an amount of the poria sclerotium is defined as XC [mass%], it is preferred that the following relation is satisfied: 0.000025
Figure 105139492-A0305-02-0002-1
XC/XA

Description

潔牙劑 dentifrice

本發明係關於一種口腔用組成物。 The present invention relates to an oral composition.

作為口腔用組成物,有從僅物理性去除附著於牙齒之污垢之口腔用組成物到希望產生各種藥效而調配有藥效成分之口腔用組成物的各種口腔用組成物。 As the oral composition, there are various oral compositions ranging from those that physically remove dirt adhering to the teeth to those that are formulated with medicinal components in order to produce various medicinal effects.

尤其,含有作為源自天然物質之成分之植物成分(尤其具有較長歷史之生藥(crude drug)成分)之口腔用組成物具有生理活性,進而與源自非天然物質之成分相比於安全性方面更優異,故而於該技術領域中尤其需要。(參考專利文獻1至3)。 In particular, oral compositions containing botanical ingredients (especially crude drug ingredients with a long history) that are ingredients derived from natural substances have physiological activity, and are therefore safer than ingredients derived from non-natural substances The aspect is more excellent, so it is especially needed in this technical field. (Refer to Patent Documents 1 to 3).

近年來,對口腔用組成物要求進一步提高預防口臭功效。 In recent years, further improvement in the effect of preventing bad breath has been demanded for oral compositions.

[先前技術文獻] [Prior Art Literature] [專利文獻] [Patent Literature]

專利文獻1:日本專利特開2015-54847號公報。 Patent Document 1: Japanese Patent Laid-Open No. 2015-54847.

專利文獻2:日本專利特開平6-25000號公報。 Patent Document 2: Japanese Patent Laid-Open No. 6-25000.

專利文獻3:日本專利特開2011-256136號公報。 Patent Document 3: Japanese Patent Laid-Open No. 2011-256136.

本發明之目的在於提供一種具有預防口臭功效之口腔用組成物,其調配有複數種生藥,與使用單獨之生藥相比可以低藥量獲得功效。 The object of the present invention is to provide an oral composition having the effect of preventing bad breath, which is prepared with a plurality of crude drugs, and can obtain the effect at a lower dose than using the crude drug alone.

此種目的可藉由下述(1)至(5)之本發明而達成。 Such objects can be achieved by the present invention of the following (1) to (5).

(1)一種口腔用組成物,其含有黃芩、桂皮及茯苓。 (1) An oral composition containing Scutellaria baicalensis, cinnamon bark, and Poria cocos.

(2)如前述(1)所記載之口腔用組成物,其中將前述口腔用組成物中之前述黃芩之含有率設為XA[質量%]、將前述口腔用組成物中之前述桂皮之含有率設為XB[質量%]時,滿足0.00005≦XB/XA≦20000之關係。 (2) The oral composition according to the above (1), wherein the content of the Scutellaria baicalensis in the oral composition is X A [mass %], and the content of the cinnamon in the oral composition is When the content rate is X B [mass %], the relationship of 0.00005≦X B /X A ≦20000 is satisfied.

(3)如前述(1)或(2)所記載之口腔用組成物,其中將前述口腔用組成物中之前述黃芩之含有率設為XA[質量%]、將前述口腔用組成物中之前述茯苓之含有率設為XC[質量%]時,滿足0.000025≦XC/XA≦40000之關係。 (3) The oral composition according to the above (1) or (2), wherein the content of the Scutellaria baicalensis in the oral composition is X A [mass %], and the oral composition is When the content rate of the above-mentioned Poria is set as X C [mass %], the relationship of 0.000025≦X C /X A ≦40000 is satisfied.

(4)如前述(1)至(3)中任一項所記載之口腔用組成物, 其中將前述口腔用組成物中之前述桂皮之含有率設為XB[質量%]、將前述口腔用組成物中之前述茯苓之含有率設為XC[質量%]時,滿足0.000025≦XC/XB≦40000之關係。 (4) The oral composition according to any one of the above (1) to (3), wherein the content of the cinnamon bark in the oral composition is X B [mass %], and the oral composition is When X C [mass %] is used as the content rate of the said Poria in the composition, the relationship of 0.000025≦X C /X B ≦40000 is satisfied.

(5)如前述(1)至(4)中任一項所記載之口腔用組成物,其含有作為萃取物之前述黃芩、前述桂皮及前述茯苓中之至少一者。 (5) The oral composition according to any one of the above (1) to (4), which contains at least one of the Scutellaria baicalensis, the cinnamon bark, and the Poria cocos as an extract.

藉由本發明,可提供一種具有預防口臭功效之口腔用組成物,其調配有複數種生藥,與使用單獨之生藥相比可以低藥量獲得功效。 According to the present invention, an oral composition having a halitosis preventive effect can be provided, which is prepared with a plurality of crude drugs and can obtain the effect at a lower dose than using a single crude drug.

以下,對本發明之較佳實施形態進行詳細說明。 Hereinafter, preferred embodiments of the present invention will be described in detail.

《口腔用組成物》 "Oral Composition"

作為口腔用組成物,有從僅物理性去除附著於牙齒之污垢之口腔用組成物到希望產生各種藥效而調配有藥效成分之口腔用組成物的各種口腔用組成物。 As the oral composition, there are various oral compositions ranging from those that physically remove dirt adhering to the teeth to those that are formulated with medicinal components in order to produce various medicinal effects.

尤其,含有作為源自天然物質之成分之植物成分(尤 其具有較長歷史之生藥成分)之口腔用組成物具有生理活性,進而與源自非天然物質之成分相比於安全性方面更優異,故而於該技術領域中尤其受到需求。 In particular, containing botanical ingredients as ingredients derived from natural substances (especially The oral composition, which has a long history of crude drug ingredients), has physiological activity and is more excellent in safety than ingredients derived from non-natural substances, and is therefore particularly demanded in this technical field.

近年來,對口腔用組成物要求進一步提高預防口臭功效。 In recent years, further improvement in the effect of preventing bad breath has been demanded for oral compositions.

因此,本發明者進行潛心研究,結果發現藉由於各種生藥中組合使用黃芩、桂皮及茯苓於口腔用組成物中,可使該等起到相乘作用,獲得優異之功效。 Therefore, the inventors of the present invention conducted intensive research, and found that by combining Scutellaria baicalensis, cinnamon bark, and Poria cocos in various crude drugs in oral compositions, these can be synergistically exerted to obtain excellent efficacy.

亦即,本發明之口腔用組成物含有黃芩、桂皮及茯苓。藉由含有黃芩、桂皮及茯苓,可獲得優異之預防口臭功效。尤其,即使在於使用單獨之生藥之情形時完全無法獲得功效之較低含有率之情形下,亦可獲得充分優異之預防口臭功效。 That is, the oral composition of the present invention contains Scutellaria baicalensis, cinnamon bark, and Poria cocos. By containing Scutellaria baicalensis, cinnamon bark and Poria cocos, excellent halitosis prevention effect can be obtained. In particular, even in the case of using the crude drug alone, even in the case of a low content rate where no effect can be obtained at all, a sufficiently excellent effect of preventing bad breath can be obtained.

再者,前述文獻中有對各種生藥之說明,但並無具體關於組合使用黃芩、桂皮及茯苓之口腔用組成物之揭示。 Furthermore, the aforementioned documents have descriptions of various crude drugs, but there is no specific disclosure about the oral composition of Scutellaria baicalensis, Cinnamon bark, and Poria cocos.

於本發明中,口腔用組成物可例如將乾燥狀態之植物粉碎而直接含有黃芩、桂皮及茯苓,亦可作為使用水或有機溶劑等萃取溶劑或超臨界流體等萃取介質而萃取之萃取成分、或自該萃取成分去除萃取介質而獲得之成分(以下,將該等統稱為萃取物)而含有。 In the present invention, the oral composition can directly contain Scutellaria baicalensis, Cinnamon bark and Poria cocos by pulverizing plants in a dry state, or can be used as an extraction component extracted using an extraction solvent such as water or an organic solvent or an extraction medium such as a supercritical fluid, Or the components obtained by removing the extraction medium from the extraction components (hereinafter, these are collectively referred to as extracts) are contained.

尤其,較佳為口腔用組成物含有作為萃取物之黃芩、桂皮及茯苓中之至少一者,更佳為含有作為萃取物之黃芩、桂皮及茯苓之全部。 In particular, it is preferable that the oral composition contains at least one of Scutellaria baicalensis, cinnamon bark, and Poria cocos as extracts, and it is more preferable to contain all of Scutellaria baicalensis, cinnamon bark, and Poria cocos as extracts.

藉此,可抑制製造批次間之品質不均,可獲得穩定之品質。 Thereby, quality unevenness between manufacturing batches can be suppressed, and stable quality can be obtained.

又,口腔用組成物中,可以較高含有率含有源自天然物質之成分中之較佳成分,可將欠佳成分之含有率抑制為較低。其結果,例如可防止口腔用組成物之色調、風味等下降,並且可更確實地發揮所期待之功效。又,可獲得口腔用組成物中之有效成分之更優異之穩定性。因此,作為口腔用組成物整體之保存穩定性提高,可進一步延長口腔用組成物之使用期限,可謀求保存條件之緩解等。 Moreover, in a composition for oral cavity, a preferable component among the components derived from a natural substance can be contained in a high content rate, and the content rate of an unsatisfactory component can be suppressed low. As a result, for example, the color tone, flavor, etc. of the oral composition can be prevented from being lowered, and the desired effect can be more reliably exhibited. In addition, more excellent stability of the active ingredient in the oral composition can be obtained. Therefore, the storage stability of the entire oral composition can be improved, the useful life of the oral composition can be further extended, and the storage conditions can be eased.

作為用以獲得黃芩、桂皮及茯苓之萃取物之萃取溶劑,例如可使用各種無機溶劑、各種有機溶劑。更具體而言,可列舉:水;甲醇、乙醇、丙醇、異丙醇、丁醇、異丁醇、辛醇、苯酚等一元醇;丙二醇、1,3-丁二醇、1,2-丁二醇、1,4-丁二醇、1,5-戊二醇、1,2-戊二醇、1,3-戊二醇、1,4-戊二醇、1,3,5-戊三醇、甘油、聚乙二醇(分子量100萬至10萬)等多元醇;丙酮、甲基乙基酮等酮類;乙酸乙酯、乙酸甲酯等酯類;二乙醚、二甲醚、乙基甲醚、 二噁烷等醚類;乙腈等腈類;氯仿、四氯化碳等鹵化物;己烷、辛烷、環己烷等脂肪族烴;二甲苯、甲苯、苯等芳香族烴等,可組合使用選自該等之一種或兩種以上。又,作為萃取溶劑,亦可使用適宜調節當量濃度之酸(例如鹽酸、硫酸、硝酸、磷酸、甲酸、乙酸等)或鹼(例如氫氧化鈉、氫氧化鉀、氫氧化鈣、氨等)。 As the extraction solvent for obtaining the extracts of Scutellaria baicalensis, cinnamon bark, and Poria cocos, for example, various inorganic solvents and various organic solvents can be used. More specifically, water; monohydric alcohols such as methanol, ethanol, propanol, isopropanol, butanol, isobutanol, octanol, and phenol; propylene glycol, 1,3-butanediol, 1,2- Butanediol, 1,4-butanediol, 1,5-pentanediol, 1,2-pentanediol, 1,3-pentanediol, 1,4-pentanediol, 1,3,5- Polyols such as pentanetriol, glycerol, polyethylene glycol (molecular weight 1 million to 100,000); ketones such as acetone and methyl ethyl ketone; esters such as ethyl acetate and methyl acetate; diethyl ether and dimethyl ether , ethyl methyl ether, Ethers such as dioxane; nitriles such as acetonitrile; halides such as chloroform and carbon tetrachloride; aliphatic hydrocarbons such as hexane, octane, and cyclohexane; aromatic hydrocarbons such as xylene, toluene, and benzene, etc., which can be combined One or two or more selected from these are used. Further, as the extraction solvent, an acid (for example, hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, formic acid, acetic acid, etc.) or a base (for example, sodium hydroxide, potassium hydroxide, calcium hydroxide, ammonia, etc.) whose normal concentration is appropriately adjusted can also be used.

其中,作為用以獲得黃芩之萃取物之萃取溶劑,較佳為使用乙醇水溶液。 Among them, as the extraction solvent for obtaining the extract of Scutellaria baicalensis, it is preferable to use an aqueous ethanol solution.

藉此,可更顯著地發揮前述功效。 Thereby, the aforementioned effects can be exerted more remarkably.

尤其,用以獲得黃芩之萃取物之萃取溶劑之乙醇水溶液之濃度(乙醇之含有率)較佳為30體積%以上95體積%以下,更佳為40體積%以上70體積%以下。 In particular, the concentration of the aqueous ethanol solution (the ethanol content) of the extraction solvent used to obtain the extract of Scutellaria baicalensis is preferably 30 vol% or more and 95 vol% or less, more preferably 40 vol% or more and 70 vol% or less.

藉此,可進一步顯著發揮前述功效。 Thereby, the aforementioned effects can be further remarkably exerted.

又,作為用以獲得桂皮之萃取物之萃取溶劑,較佳為含有水之溶劑。 Moreover, as an extraction solvent for obtaining the cinnamon bark extract, the solvent containing water is preferable.

藉此,可更顯著地發揮前述功效。 Thereby, the aforementioned effects can be exerted more remarkably.

尤其,用以獲得桂皮之萃取物之萃取溶劑中所含之水之含有率較佳為90質量%以上,更佳為95質量%以上。 In particular, the content rate of water contained in the extraction solvent for obtaining the cinnamon bark extract is preferably 90% by mass or more, more preferably 95% by mass or more.

藉此,可進一步顯著發揮前述功效。 Thereby, the aforementioned effects can be further remarkably exerted.

又,作為用以獲得茯苓之萃取物之萃取溶劑,較佳為使用乙醇水溶液。 Moreover, it is preferable to use an ethanol aqueous solution as an extraction solvent for obtaining the extract of Poria cocos.

藉此,可更顯著地發揮前述功效。 Thereby, the aforementioned effects can be exerted more remarkably.

尤其,用以獲得茯苓之萃取物之萃取溶劑之乙醇水溶液之濃度(乙醇之含有率)較佳為30體積%以上95體積%以下,更佳為45體積%以上85體積%以下。 In particular, the concentration of the aqueous ethanol solution (the ethanol content) of the extraction solvent used to obtain the Poria cocos extract is preferably 30 vol% or more and 95 vol% or less, more preferably 45 vol% or more and 85 vol% or less.

藉此,可進一步顯著發揮前述功效。 Thereby, the aforementioned effects can be further remarkably exerted.

於口腔用組成物中,可以任何形態含有黃芩、桂皮及茯苓,例如可以粉末、粒體狀含有,亦可作為油狀成分而含有,亦可以溶解於其他成分之狀態含有。 The oral composition may contain Scutellaria baicalensis, cinnamon bark, and Poria in any form, for example, in powder or granular form, as an oily component, or dissolved in other components.

口腔用組成物中之黃芩之含有率(乾燥狀態之黃芩之含有率)並無特別限定,較佳為0.00001質量%以上10質量%以下,更佳為0.0001質量%以上2.0質量%以下,進而較佳為0.0005質量%以上0.05質量%以下。 The content of Scutellaria baicalensis in the oral composition (the content of Scutellaria baicalensis in dry state) is not particularly limited, but is preferably 0.00001 mass % or more and 10 mass % or less, more preferably 0.0001 mass % or more and 2.0 mass % or less, and more preferably Preferably it is 0.0005 mass % or more and 0.05 mass % or less.

若黃芩之含有率未達前述下限值,則根據桂皮、茯苓之含有率等,存在未充分發揮本發明所產生之功效的可能性。 If the content rate of Scutellaria baicalensis does not reach the said lower limit, there exists a possibility that the effect by this invention may not fully be exhibited depending on the content rate of cassia bark, Poria, etc.

又,若黃芩之含有率超過前述上限值,則存在更顯著地發生著色之問題或因苦味等異味等而導致之使用感下 降等問題的情形。 In addition, when the content rate of Scutellaria baicalensis exceeds the above-mentioned upper limit value, there is a problem that coloring occurs more remarkably, and a feeling of use is deteriorated due to an odor such as bitterness. downgrade problems.

口腔用組成物中之桂皮之含有率(乾燥狀態之桂皮之含有率)並無特別限定,較佳為0.00001質量%以上10質量%以下,更佳為0.0001質量%以上2.0質量%以下,進而較佳為0.0008質量%以上0.1質量%以下。 The content of cinnamon in the oral composition (content of cassia in dry state) is not particularly limited, but is preferably 0.00001 mass % or more and 10 mass % or less, more preferably 0.0001 mass % or more and 2.0 mass % or less, and more Preferably it is 0.0008 mass % or more and 0.1 mass % or less.

若桂皮之含有率未達前述下限值,則根據黃芩、茯苓之含有率等,存在未充分發揮本發明所產生之功效的可能性。 If the content rate of cassia bark is less than the said lower limit, there exists a possibility that the effect by this invention may not fully be exhibited according to the content rate of Scutellaria baicalensis, Poria, etc.

又,若桂皮之含有率超過前述上限值,則存在更顯著地發生著色之問題或因苦味等異味等而導致之使用感下降等問題的情形。 Moreover, when the content rate of a cinnamon bark exceeds the said upper limit, the problem of coloring, and the problem of a feeling of use reduction by peculiar smells, such as bitterness, etc. may arise more remarkably.

口腔用組成物中之茯苓之含有率(乾燥狀態之茯苓之含有率)並無特別限定,較佳為0.00001質量%以上10質量%以下,更佳為0.00005質量%以上4.0質量%以下,進而較佳為0.002質量%以上1.0質量%以下。 The content rate of Poria cocos in the oral composition (content rate of Poria cocos in a dry state) is not particularly limited, but is preferably 0.00001 mass % or more and 10 mass % or less, more preferably 0.00005 mass % or more and 4.0 mass % or less, and more preferably Preferably it is 0.002 mass % or more and 1.0 mass % or less.

若茯苓之含有率未達前述下限值,則根據黃芩、桂皮之含有率等,存在未充分發揮本發明所產生之功效的可能性。 If the content rate of Poria cocos does not reach the said lower limit, there exists a possibility that the effect by this invention may not fully be exhibited according to the content rate of Scutellaria baicalensis, cinnamon bark, etc.

又,若茯苓之含有率超過前述上限值,則存在更顯著地發生著色之問題或因苦味等異味等而導致之使用感下降等問題的情形。 Moreover, when the content rate of Poria cocos exceeds the said upper limit value, the problem of coloring, the problem of the fall in use feeling by odor, etc., such as bitterness, may arise more remarkably.

將口腔用組成物中之黃芩之含有率設為XA[質量%]、將口腔用組成物中之桂皮之含有率設為XB[質量%]時,較佳為滿足0.00005≦XB/XA≦20000之關係,更佳為滿足0.015≦XB/XA≦200之關係,進而較佳為滿足0.03≦XB/XA≦100之關係。 When the content rate of Scutellaria baicalensis in the oral composition is X A [mass %] and the content rate of cinnamon in the oral composition is X B [mass %], it is preferable to satisfy 0.00005≦X B / The relationship of X A ≦20000 is more preferably satisfied the relationship of 0.015≦X B /X A ≦200, and more preferably the relationship of 0.03≦X B /X A ≦100 is satisfied.

藉此,可獲得更優異之預防口臭功效,同時可獲得口腔用組成物之更優異之保存穩定性等。 Thereby, a more excellent effect of preventing bad breath can be obtained, and at the same time, a more excellent storage stability of the oral composition can be obtained.

將口腔用組成物中之黃芩之含有率設為XA[質量%]、將口腔用組成物中之茯苓之含有率設為XC[質量%]時,較佳為滿足0.000025≦XC/XA≦40000之關係,更佳為滿足0.04≦XC/XA≦2000之關係,進而較佳為滿足0.1≦XC/XA≦1000之關係。 When the content rate of Scutellaria baicalensis in the oral composition is X A [mass %] and the content rate of Poria cocos in the oral composition is X C [mass %], it is preferable to satisfy 0.000025≦X C / The relationship of X A ≦40000 is more preferably satisfied the relationship of 0.04≦X C /X A ≦2000, and more preferably the relationship of 0.1≦X C /X A ≦1000 is satisfied.

藉此,可獲得更優異之預防口臭功效,同時可獲得口腔用組成物之更優異之保存穩定性等。 Thereby, a more excellent effect of preventing bad breath can be obtained, and at the same time, a more excellent storage stability of the oral composition can be obtained.

將口腔用組成物中之桂皮之含有率設為XB[質量%]、將口腔用組成物中之茯苓之含有率設為XC[質量%]時,較 佳為滿足0.000025≦XC/XB≦40000之關係,更佳為滿足0.02≦XC/XB≦1250之關係,進而較佳為滿足0.05≦XC/XB≦700之關係。 When the content rate of cinnamon in the oral composition is X B [mass %] and the content rate of Poria cocos in the oral composition is X C [mass %], it is preferable to satisfy 0.000025≦X C / The relationship of X B ≦40000 is more preferably satisfied the relationship of 0.02≦X C /X B ≦1250, and more preferably the relationship of 0.05≦X C /X B ≦700 is satisfied.

藉此,可獲得更優異之預防口臭功效,同時可獲得口腔用組成物之更優異之保存穩定性等。 Thereby, a more excellent effect of preventing bad breath can be obtained, and at the same time, a more excellent storage stability of the oral composition can be obtained.

本發明之口腔用組成物可含有前述以外之成分。 The oral composition of the present invention may contain components other than those described above.

作為此種成分(其他成分),例如可列舉:研磨劑、濕潤劑、溶劑、黏結劑、香料、賦形劑、甜味劑、pH值調整劑、防腐劑、乳化劑、助溶劑、發泡劑、潤滑劑、油、界面活性劑、著色劑、抗氧化劑、螯合劑、調味劑、保濕劑、抗菌劑、抗炎劑、氟化物、維生素劑、前述以外之生藥等。 Examples of such components (other components) include abrasives, wetting agents, solvents, binders, fragrances, excipients, sweeteners, pH adjusters, preservatives, emulsifiers, solubilizers, foaming agents Agents, lubricants, oils, surfactants, colorants, antioxidants, chelating agents, flavoring agents, moisturizing agents, antibacterial agents, anti-inflammatory agents, fluorides, vitamin agents, crude drugs other than the above, and the like.

作為研磨劑,例如可列舉:矽膠、沈澱二氧化矽、火成二氧化矽、含水矽酸、無水矽酸、鋁矽酸鹽、鋯矽酸鹽等二氧化矽系研磨劑;二水合磷酸氫鈣、無水合磷酸氫鈣等潔牙用磷酸氫鈣;輕質碳酸鈣、重質碳酸鈣等碳酸鈣;磷酸鈣、磷酸三鎂、磷酸三鈣、不溶性偏磷酸鈣、焦磷酸鈣、氫氧化鋁、氧化鋁、碳酸鎂、矽酸鋯、二氧化鈦、合成樹脂系研磨劑、沸石等,可組合使用選自該等之一種或兩種以上。 Examples of abrasives include silica-based abrasives such as silica gel, precipitated silica, fumed silica, hydrous silicic acid, anhydrous silicic acid, aluminosilicate, and zirconium silicate; dihydrate hydrogen phosphate Calcium, calcium hydrogen phosphate anhydrous and other calcium hydrogen phosphate for dental cleaning; light calcium carbonate, heavy calcium carbonate and other calcium carbonate; calcium phosphate, trimagnesium phosphate, tricalcium phosphate, insoluble calcium metaphosphate, calcium pyrophosphate, hydroxide Aluminum, alumina, magnesium carbonate, zirconium silicate, titanium dioxide, synthetic resin-based abrasives, zeolite, etc., may be used in combination of one or two or more selected from these.

尤其,較佳為口腔用組成物含有由多孔質體構成之研 磨劑。 In particular, it is preferable that the oral composition contains a abrasive.

藉此,可於研磨劑(多孔質體)之空孔內擔載前述生藥成分(尤其黃芩之萃取物、桂皮之萃取物、茯苓之萃取物),從而減輕生藥之苦味。 Thereby, the above-mentioned crude drug ingredients (especially the extract of Scutellaria baicalensis, the extract of cinnamon, and the extract of Poria cocos) can be supported in the pores of the abrasive (porous body), thereby reducing the bitterness of the crude drug.

前述各種研磨劑中,尤佳為使用沸石。 Among the above-mentioned various abrasives, it is particularly preferable to use zeolite.

藉由使用沸石,可更佳地於研磨劑(多孔質體)之空孔內擔載生藥成分(尤其黃芩之萃取物、桂皮之萃取物、茯苓之萃取物),從而減輕生藥之苦味。 By using zeolite, the crude drug ingredients (especially the extract of Scutellaria baicalensis, the extract of cinnamon, and the extract of Poria cocos) can be better supported in the pores of the abrasive (porous body), thereby reducing the bitterness of the crude drug.

作為濕潤劑,例如可列舉:甘油、山梨糖醇、聚乙二醇、丙二醇、乙二醇、1,3-丁二醇、聚丙二醇、木糖醇、麥芽糖醇、乳糖醇等多元醇等,可組合使用選自該等之一種或兩種以上。 Examples of the wetting agent include polyhydric alcohols such as glycerin, sorbitol, polyethylene glycol, propylene glycol, ethylene glycol, 1,3-butanediol, polypropylene glycol, xylitol, maltitol, and lactitol. One kind or two or more kinds selected from these can be used in combination.

作為溶劑,例如較佳為醇等有機溶劑或水,例如可列舉:乙醇、丙醇、異丙醇等,尤佳為乙醇。 As a solvent, an organic solvent, such as alcohol, or water is preferable, for example, ethanol, propanol, isopropanol, etc. are mentioned, for example, ethanol is especially preferable.

作為黏結劑,例如可列舉:卡拉膠、羧甲基纖維素、羧甲基纖維素鈉等纖維素衍生物;褐藻酸鈉等鹼金屬褐藻酸鹽;三仙膠、黃蓍膠、阿拉伯膠等膠類;聚乙烯醇、聚丙烯酸鈉等合成黏結劑等,可組合使用選自該等之一種或兩種以上。 Examples of the binder include cellulose derivatives such as carrageenan, carboxymethyl cellulose, and sodium carboxymethyl cellulose; alkali metal alginates such as sodium alginate; gum sanxian, gum tragacanth, gum arabic, etc. Adhesives; synthetic binders such as polyvinyl alcohol and sodium polyacrylate, etc., one or more of them can be used in combination.

作為香料,例如可列舉:草莓香料、蘋果香料、香蕉香料、鳳梨香料、葡萄香料、芒果香料、乳酪香料、牛乳香料、水果混合香料、熱帶水果香料等調合香料等公知之香料素材等,可組合使用選自該等之一種或兩種以上。 Examples of the flavor include known flavoring materials such as strawberry flavor, apple flavor, banana flavor, pineapple flavor, grape flavor, mango flavor, cheese flavor, milk flavor, fruit blend flavor, tropical fruit flavor, and other blended flavors, and the like can be combined. One or two or more selected from these are used.

作為賦形劑,例如可列舉:蔗糖、乳糖、澱粉、葡萄糖、結晶性纖維素、甘露醇、山梨糖醇、木糖醇、赤絲藻醇(erythritol)、異麥芽糖醇(Palatinit)、巴拉金糖、麥芽糖醇、海藻糖、乳糖醇、乳酮糖、還原澱粉糖、還原異麥芽寡糖、配聯糖、膠基、阿拉伯膠、明膠、十六烷基甲基纖維素、輕質無水矽酸、鋁酸鎂、偏矽酸鋁酸鈣、碳酸氫鈉、磷酸鈣等,可組合使用選自該等之一種或兩種以上。 Examples of excipients include: sucrose, lactose, starch, glucose, crystalline cellulose, mannitol, sorbitol, xylitol, erythritol, isomalt (Palatinit), paratha Gold sugar, maltitol, trehalose, lactitol, lactulose, reduced starch sugar, reduced isomalt oligosaccharide, glycoside, gum base, gum arabic, gelatin, cetyl methyl cellulose, light Anhydrous silicic acid, magnesium aluminate, calcium aluminate metasilicate, sodium bicarbonate, calcium phosphate, etc., may be used in combination of one or two or more selected from these.

作為甜味劑,例如可列舉:異麥芽糖醇、阿斯巴甜、糖精鈉、乙醯磺胺酸鉀、甜菊苷、新橘皮苷二氫查酮、甘草素、紫蘇糖(perillartine)、索馬甜(thaumatin)、天冬胺醯苯丙胺酸甲酯、對甲苯基桂皮醛等,可組合使用選自該等之一種或兩種以上。 Examples of sweeteners include isomalt, aspartame, sodium saccharin, acesulfame potassium, stevioside, neohesperidin dihydrochadone, licorice, perillartine, soma Sweet (thaumatin), methyl aspartame, p-tolyl cinnamaldehyde, etc., can be used in combination of one or two or more selected from these.

作為pH值調整劑,例如可列舉:檸檬酸、磷酸、泛酸、蘋果酸、焦磷酸、乳酸、酒石酸、甘油磷酸、乙酸、硝酸或磷酸氫二鈉等該等之化學上可能之鹽或氫氧化鈉等。該等可以組成物之pH值成為適當之範圍之方式組合 使用選自該等之一種或兩種以上。 Examples of pH adjusters include chemically possible salts or hydroxides such as citric acid, phosphoric acid, pantothenic acid, malic acid, pyrophosphoric acid, lactic acid, tartaric acid, glycerophosphoric acid, acetic acid, nitric acid, and disodium hydrogen phosphate. sodium etc. These can be combined in such a way that the pH of the composition becomes an appropriate range One or two or more selected from these are used.

作為防腐劑,例如可列舉:對羥基苯甲酸酯類、苯甲酸及其鹽、水楊酸及其鹽、山梨酸及其鹽、苯氧乙醇、鹽酸烷基二胺基乙基甘胺酸等,可組合使用選自該等之一種或兩種以上。 Examples of preservatives include parabens, benzoic acid and its salts, salicylic acid and its salts, sorbic acid and its salts, phenoxyethanol, alkyldiaminoethylglycine hydrochloride, and the like , can be used in combination of one or two or more selected from these.

作為乳化劑,例如可列舉:聚氧乙烯烷基醚、聚氧乙烯脂肪酸酯、聚氧乙烯山梨醇酐脂肪酸酯、山梨醇酐脂肪酸酯、甘油脂肪酸酯、聚甘油脂肪酸酯、聚氧乙烯氫化蓖麻油、硬脂醯乳酸鈉、大豆磷脂、氯化烷基三甲基銨等,可組合使用選自該等之一種或兩種以上。 Examples of emulsifiers include polyoxyethylene alkyl ethers, polyoxyethylene fatty acid esters, polyoxyethylene sorbitan fatty acid esters, sorbitan fatty acid esters, glycerol fatty acid esters, polyglycerol fatty acid esters, Polyoxyethylene hydrogenated castor oil, sodium stearyl lactate, soybean lecithin, alkyltrimethylammonium chloride, etc., may be used in combination of one or two or more selected from these.

作為助溶劑,例如可列舉:酯類、聚乙二醇衍生物、聚氧乙烯氫化蓖麻油、山梨醇酐之脂肪酸酯類、硫酸化脂肪醇類等,可組合使用選自該等之一種或兩種以上。 Examples of cosolvents include esters, polyethylene glycol derivatives, polyoxyethylene hydrogenated castor oil, fatty acid esters of sorbitan, sulfated fatty alcohols, and the like, and one or more selected from these may be used in combination. two or more.

作為發泡劑,例如可列舉:月桂基硫酸鈉、月桂醯基肌胺酸鈉、烷基磺基琥珀酸鈉、椰子油脂肪酸單甘油磺酸鈉、α-烯烴磺酸鈉、N-醯基麩胺酸鹽等N-醯基胺基酸鹽、2-烷基-N-羧甲基-N-羥乙基咪唑啉甜菜鹼、麥芽糖醇脂肪酸酯、蔗糖脂肪酸酯、聚甘油脂肪酸酯、脂肪酸二乙醇醯胺、聚氧乙烯山梨醇酐單硬脂酸酯、聚氧乙烯氫化蓖麻油、聚氧乙烯脂肪酸酯等,可組合使用選自該等之一種或 兩種以上。 As the foaming agent, for example, sodium lauryl sulfate, sodium lauryl sarcosinate, sodium alkyl sulfosuccinate, sodium coconut fatty acid monoglycerol sulfonate, sodium α-olefin sulfonate, N-sulfonic acid sodium N-Amino acid salts such as glutamate, 2-Alkyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine, maltitol fatty acid esters, sucrose fatty acid esters, polyglycerol fatty acids Esters, fatty acid diethanolamide, polyoxyethylene sorbitan monostearate, polyoxyethylene hydrogenated castor oil, polyoxyethylene fatty acid ester, etc., can be used in combination with one selected from these or two or more.

作為潤滑劑,例如可列舉:硬脂酸鎂、蔗糖脂肪酸酯、滑石、硬化油等,可組合使用選自該等之一種或兩種以上。 Examples of the lubricant include magnesium stearate, sucrose fatty acid ester, talc, hardened oil, and the like, and one or two or more selected from these can be used in combination.

作為油,例如可列舉:椰子油、橄欖油、芝麻油、花生油、洋芹油、香芹籽油、紅花油等,可組合使用選自該等之一種或兩種以上。 Examples of oils include coconut oil, olive oil, sesame oil, peanut oil, parsley oil, parsley seed oil, safflower oil, and the like, and one or two or more selected from these can be used in combination.

作為界面活性劑,例如可列舉:月桂基硫酸鈉、α-烯烴磺酸鈉、十二烷基苯磺酸鈉、月桂基磺基乙酸鈉、N-月桂醯基肌胺酸鈉、N-醯基麩胺酸鹽、蔗糖脂肪酸酯、聚氧乙烯氫化蓖麻油、聚氧乙烯聚氧丙烯嵌段共聚物、烷基糖苷類、山梨醇酐脂肪酸酯、聚氧乙烯山梨醇酐脂肪酸酯、烷基二甲基氧化胺、月桂基乙醇醯胺、椰子油脂醯肌胺酸鈉、N-月桂醯甲基牛磺酸鈉液等,可組合使用選自該等之一種或兩種以上。 As the surfactant, for example, sodium lauryl sulfate, sodium α-olefin sulfonate, sodium dodecylbenzenesulfonate, sodium lauryl sulfoacetate, sodium N-lauryl sarcosinate, N- Glutamate, sucrose fatty acid ester, polyoxyethylene hydrogenated castor oil, polyoxyethylene polyoxypropylene block copolymer, alkyl glycosides, sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester , alkyl dimethyl amine oxide, lauryl glycolamide, coconut oil sodium sarcosinate, N-lauryl methyl taurine sodium solution, etc., can be used in combination with one or two or more selected from these.

作為著色劑,例如可列舉:藍色1號等色素、二氧化鈦等顏料或各種染料等,可組合使用選自該等之一種或兩種以上。 Examples of the colorant include dyes such as blue No. 1, pigments such as titanium dioxide, various dyes, and the like, and one or two or more selected from these can be used in combination.

作為抗氧化劑,例如可列舉:二丁基羥基甲苯、丁基羥基苯甲醚、異抗壞血酸、沒食子酸丙酯、沒食子酸辛酯、 d-α-生育酚、維生素C、維生素E、乙二胺四乙酸二鈉、葡萄糖酸鈣等。 Examples of antioxidants include dibutylhydroxytoluene, butylhydroxyanisole, erythorbic acid, propyl gallate, octyl gallate, d-α-tocopherol, vitamin C, vitamin E, disodium EDTA, calcium gluconate, etc.

作為螯合劑,例如可列舉:乙二胺四乙酸鹽等。 As a chelating agent, ethylenediaminetetraacetate etc. are mentioned, for example.

作為調味劑,例如可列舉:茶萃取物、茶乾餾液、麩胺酸鈉等,可組合使用選自該等之一種或兩種以上。 As a flavoring agent, a tea extract, tea dry distillation liquid, sodium glutamate, etc. are mentioned, for example, One or two or more types selected from these can be used in combination.

作為保濕劑,例如可列舉:胺基酸或其鹽、吡咯啶酮羧酸、黏蛋白、玻尿酸或其鹽、硫酸軟骨膠等黏多醣類、乳酸鈉、脲、泛醇(panthenol)、蘆薈萃取物、迷迭香萃取物、麝香草萃取物、茶萃取物(茶乾餾萃取物)等天然萃取成分、膠蛋白、彈性蛋白等所謂的細胞外基質等,可組合使用選自該等之一種或兩種以上。 Examples of the moisturizing agent include amino acid or its salt, pyrrolidone carboxylic acid, mucin, hyaluronic acid or its salt, mucopolysaccharides such as chondroitin sulfate, sodium lactate, urea, panthenol, and aloe vera extract. Natural extracts such as extracts, rosemary extracts, thyme extracts, tea extracts (tea dry distillation extracts), so-called extracellular matrices such as collagen and elastin, etc., one or more selected from these can be used in combination. two or more.

作為抗菌劑,例如可列舉:異丙基甲基苯酚、三氯沙、日本扁柏油、百里酚等酚系抗菌劑;氯化十六烷基吡啶、氯化苄烷銨(benzalkonium chloride)、氯化本索寧(benzethonium chloride)、地喹氯銨(dequalinium chlorid)、氯己定鹽酸鹽(chlorhexidine hydrochloride)、氯己定葡萄糖酸鈉、沒藥醇氯己定(bisabolol Chlorhexidine)、乳鐵蛋白(lactoferrin)、對羥苯甲酸酯(paraben)、對羥苯甲酸丁酯等,可組合使用選自該等之一種或兩種以上。 Examples of antibacterial agents include phenol-based antibacterial agents such as isopropylmethylphenol, triclosan, cypress oil, and thymol; cetylpyridinium chloride, benzalkonium chloride, benzethonium chloride, dequalinium chlorid, chlorhexidine hydrochloride, sodium chlorhexidine gluconate, bisabolol Chlorhexidine, lactoferrin Protein (lactoferrin), paraben, butylparaben, etc., can be used in combination of one or two or more selected from these.

作為抗炎劑,例如可列舉:氯化溶菌酶、ε-胺基己 酸、羥基尿囊素鋁、甘草酸、甘草素酸鹽類、癒創甘菊環磺酸、乙酸dl-α-生育酚等,可組合使用選自該等之一種或兩種以上。 Examples of anti-inflammatory agents include lysozyme chloride, ε-aminohexan Acid, aluminum hydroxyallantoin, glycyrrhizic acid, salts of glycyrrhizinate, guaiacol sulfonic acid, dl-α-tocopherol acetate, etc., may be used in combination of one or two or more selected from these.

又,作為氟化物,例如可列舉:氟化鈉、氟化鉀、單氟磷酸鈉、二氟化錫等,可組合使用選自該等之一種或兩種以上。 Moreover, as a fluoride, sodium fluoride, potassium fluoride, sodium monofluorophosphate, tin difluoride etc. are mentioned, for example, One or two or more types selected from these can be used in combination.

作為維生素劑,例如可列舉:視黃酸、β-胡蘿蔔素等維生素A類;泛酸或其鹽類、菸鹼酸、生物素等維生素B類;抗壞血酸或其鹽類、衍生物等維生素C類;α-生育酚等維生素E類、葉酸等,可組合使用選自該等之一種或兩種以上。 Examples of vitamin agents include vitamins A such as retinoic acid and β-carotene; vitamin Bs such as pantothenic acid or its salts, nicotinic acid, and biotin; and vitamin Cs such as ascorbic acid or its salts and derivatives. ; Vitamin E such as α-tocopherol, folic acid, etc., can be used in combination of one or two or more selected from these.

作為前述以外之生藥,例如可列舉:黃金菊、纈草、棗、啤酒花、薰衣草、靈丹、木瓜、金銀花、熊笹草(sasa albo-marginata)、樹膠(Gummi)、丁香、田七人參(denshichi carrot)、一串紅、無患子、桔梗、地黃、芍藥、山楂、當歸、茶、狹葉櫟(Quercus stenophylla)、大麥(Hordeum sativum)、白樺、人參、兒茶、薑黃、迷迭香等,可組合使用選自該等之一種或兩種以上。 Examples of crude drugs other than the above include: goldenrod, valerian, jujube, hops, lavender, elixir, papaya, honeysuckle, sasa albo-marginata, gum (Gummi), clove, ginseng denshichi carrot), a bunch of red, Sapindus japonica, Campanulaceae, Rehmannia glutinosa, peony, hawthorn, angelica, tea, Quercus stenophylla, barley (Hordeum sativum), birch, ginseng, catechu, turmeric, rosemary, etc. , can be used in combination of one or two or more selected from these.

於口腔用組成物含有如前述之生藥之情形時,口腔用組成物可例如將乾燥狀態之植物粉碎而直接含有如前述 之生藥,亦可作為使用水或有機溶劑等萃取溶劑或超臨界流體等萃取介質而萃取之萃取成分、或自該萃取成分去除萃取介質而獲得之成分(萃取物)而含有。 In the case where the oral composition contains the aforementioned crude drug, the oral composition may, for example, pulverize a dried plant to directly contain the aforementioned crude drug. The crude drug may be contained as an extraction component extracted using an extraction solvent such as water or an organic solvent or an extraction medium such as a supercritical fluid, or a component (extract) obtained by removing the extraction medium from the extraction component.

口腔用組成物之形態並無特別限定,例如可列舉:液體(乳化形、可溶化形)、液狀、凝膠狀、膏狀、錠劑、發泡錠、粉末狀、顆粒狀等。 The form of the oral composition is not particularly limited, and examples thereof include liquid (emulsified form, solubilized form), liquid form, gel form, paste form, tablet, foamable tablet, powder, granule, and the like.

作為口腔用組成物之用途,例如可列舉:潔牙膏、潔牙粉、液狀潔牙劑、液體潔牙劑等潔牙劑類;口含劑;錠劑(包含發泡錠等);乳霜劑;軟膏劑;貼附劑;口腔濕潤劑;漱口劑;口香糖等。 Examples of uses of the oral composition include dentifrices such as toothpaste, dentifrice, liquid dentifrice, and liquid dentifrice; buccal preparations; lozenges (including foaming lozenges, etc.); creams Agent; ointment; patch; mouth moisturizing agent; mouthwash; chewing gum, etc.

《口腔用組成物之製造方法》 "Manufacturing method of oral composition"

本發明之口腔用組成物可藉由混合前述各成分而獲得。 The oral composition of the present invention can be obtained by mixing the aforementioned components.

尤其於口腔用組成物含有多孔質體之情形時,較佳為將如前述之黃芩、桂皮、茯苓預先與多孔質體混合後,再與其他成分混合。 In particular, when the oral composition contains a porous body, it is preferable to mix the above-mentioned Scutellaria baicalensis, cinnamon bark, and Poria cocos with the porous body in advance, and then mix them with other components.

藉此,可更佳地於多孔質體之空孔內擔載生藥。 Thereby, the crude drug can be supported in the pores of the porous body more preferably.

以上,對本發明之較佳實施形態進行了說明,但本發明並不受前述內容限定。 The preferred embodiments of the present invention have been described above, but the present invention is not limited to the foregoing.

[實施例] [Example]

以下,基於實施例及比較例對本發明進行詳細說明,但本發明並不限定於此。 Hereinafter, the present invention will be described in detail based on Examples and Comparative Examples, but the present invention is not limited thereto.

《1》液狀組成物之製造 《1》Manufacture of liquid composition

藉由以下方式製造各實施例及各比較例之液狀組成物(口腔用組成物)。 The liquid composition (oral composition) of each Example and each comparative example was produced in the following manner.

(實施例1) (Example 1)

使作為黃芩萃取物之黃芩萃取液-J(丸善製藥公司製造)之冷凍乾燥粉末、作為桂皮萃取物之桂皮萃取物W-LA(丸善製藥公司製造)及作為茯苓萃取物之茯苓萃取液(丸善製藥公司製造)之冷凍乾燥粉末以特定量(參考表1)溶解於水中而獲得液狀組成物。 The freeze-dried powder of Scutellaria baicalensis extract-J (manufactured by Maruzen Pharmaceutical Co., Ltd.) as the Scutellaria baicalensis extract, the cassia extract W-LA (manufactured by Maruzen Pharmaceutical Co., Ltd.) as the cassia bark extract, and the Poria cocos extract (manufactured by Maruzen Pharmaceutical Co., Ltd.) The freeze-dried powder (manufactured by a pharmaceutical company) was dissolved in water in a specific amount (refer to Table 1) to obtain a liquid composition.

(實施例2至10) (Examples 2 to 10)

除成為原料之各成分之含有率變更為表1所示以外,以與前述實施例1相同之方式製造液狀組成物。 A liquid composition was produced in the same manner as in Example 1 above, except that the content of each component used as a raw material was changed as shown in Table 1.

(比較例1) (Comparative Example 1)

除不使用黃芩、桂皮及茯苓作為原料以外,以與前述實施例1相同之方式製造液狀組成物。 A liquid composition was produced in the same manner as in the aforementioned Example 1, except that Scutellaria baicalensis, cinnamon bark, and Poria cocos were not used as raw materials.

(比較例2) (Comparative Example 2)

除不使用桂皮及茯苓作為原料以外,以與前述實施例1相同之方式製造液狀組成物。 A liquid composition was produced in the same manner as in the aforementioned Example 1, except that cinnamon bark and Poria cocos were not used as raw materials.

(比較例3) (Comparative Example 3)

除不使用黃芩及茯芩作為原料以外,以與前述實施例1相同之方式製造液狀組成物。 A liquid composition was produced in the same manner as in the aforementioned Example 1, except that Scutellaria baicalensis and Poria baicalensis were not used as raw materials.

(比較例4) (Comparative Example 4)

除不使用黃芩及桂皮作為原料以外,以與前述實施例1相同之方式製造液狀組成物。 A liquid composition was produced in the same manner as in the aforementioned Example 1, except that Scutellaria baicalensis and cinnamon were not used as raw materials.

(比較例5) (Comparative Example 5)

除不使用黃苓作為原料以外,以與前述實施例1相同之方式製造液狀組成物。 A liquid composition was produced in the same manner as in the aforementioned Example 1, except that Huang Ling was not used as a raw material.

(比較例6) (Comparative Example 6)

除變更桂皮及水之使用量以外,以與前述比較例3相同之方式製造液狀組成物。 A liquid composition was produced in the same manner as in Comparative Example 3 above, except that the amounts of cinnamon and water to be used were changed.

將前述各實施例及各比較例之液狀組成物之組成等總結示於表1。再者,表1中,液狀組成物中之黃芩之含有率以XA[質量%]表示,液狀組成物中之桂皮之含有率以XB[質量%]表示,液狀組成物中之茯苓之含有率以XC[質量 %]表示。 Table 1 summarizes the composition and the like of the liquid compositions in each of the aforementioned Examples and Comparative Examples. In addition, in Table 1, the content rate of Scutellaria baicalensis in the liquid composition is represented by X A [mass %], the content rate of cinnamon bark in the liquid composition is represented by X B [mass %], and the liquid composition is represented by X B [mass %]. The content of Poria cocos is represented by X C [mass %].

Figure 105139492-A0101-12-0020-1
Figure 105139492-A0101-12-0020-1

《2》評價 "2" evaluation

使用前述各實施例及各比較例之液狀組成物進行以下評價。 The following evaluations were performed using the liquid compositions of each of the foregoing Examples and each of Comparative Examples.

《2-1》除臭功效之評價 Evaluation of "2-1" Deodorant Efficacy

於小瓶中投入懸浮於磷酸緩衝生理食鹽水(亦即PBS(Phosphate-Buffered Saline;磷酸緩衝生理食鹽水))中之牙齦卟啉單胞菌(Porphyromonas gingivalis JCM12257)(O.D.0.3):4.25mL、作為被驗試料之液狀組成物:0.5mL及100mM之L-甲硫胺酸水溶液:0.25mL並混合。於密栓之狀態下於37℃下對其進行3小時厭氧培養。 Porphyromonas gingivalis (Porphyromonas gingivalis) suspended in phosphate-buffered saline (ie PBS (Phosphate-Buffered Saline; Phosphate-buffered saline)) was put into a vial JCM12257) (O.D.0.3): 4.25 mL, liquid composition as test sample: 0.5 mL, and 100 mM L-methionine aqueous solution: 0.25 mL and mixed. It was cultured anaerobically at 37°C for 3 hours in a tightly plugged state.

又,除使用蒸餾水作為被驗試料以外,以與前述方法相同之方式進行厭氧培養。將其作為對照。 In addition, anaerobic culture was performed in the same manner as the above-mentioned method except that distilled water was used as the test sample. Use this as a control.

對該等進行3小時之厭氧培養後,藉由氣相層析法測定產生菌之甲基硫醇量。 After these were subjected to anaerobic culture for 3 hours, the amount of methyl mercaptan of the producing bacteria was measured by gas chromatography.

將對照之甲基硫醇量設為100時,自100減去各實施例及各比較例所得之液狀組成物之殘留甲基硫醇量所求得之值即為除臭率(%)。依據以下基準評價該除臭率。 When the methyl mercaptan amount of the control is set as 100, the value obtained by subtracting the residual methyl mercaptan amount of the liquid composition obtained in each example and each comparative example from 100 is the deodorization rate (%) . The deodorization rate was evaluated according to the following criteria.

A:除臭率為55%以上。 A: The deodorizing rate is 55% or more.

B:除臭率為40%以上且未達55%。 B: The deodorization rate is 40% or more and less than 55%.

C:除臭率為30%以上且未達40%。 C: The deodorization rate is 30% or more and less than 40%.

D:除臭率為20%以上且未達30%。 D: The deodorizing rate is 20% or more and less than 30%.

E:除臭率未達20%。 E: The deodorization rate is less than 20%.

《2-2》色調 "2-2" Hue

對前述實施例及前述比較例之液狀組成物測定波長286nm之光之吸光度,依據以下基準進行評價。可以認 為若吸光度較小,則液狀組成物之外觀更優異。 The absorbance of light with a wavelength of 286 nm was measured for the liquid compositions of the above-mentioned examples and the above-mentioned comparative examples, and evaluated according to the following criteria. can be recognized It is because the appearance of the liquid composition is more excellent when the absorbance is small.

A:吸光度未達25.0。 A: The absorbance is less than 25.0.

B:吸光度為25.0以上。 B: The absorbance is 25.0 or more.

該等結果示於表2。又,表2中亦合併記載有前述試驗時各成分之濃度(含有率)。 These results are shown in Table 2. In addition, in Table 2, the density|concentration (content rate) of each component at the time of the said test is combined and described.

Figure 105139492-A0101-12-0022-2
Figure 105139492-A0101-12-0022-2

由表2可明瞭,於本發明中獲得優異之結果,相對於此於比較例中無法獲得滿意結果。更具體而言,由表2 之實施例1及比較例2至4可明瞭,於單獨使用黃芩、單獨使用桂皮、單獨使用茯苓時完全無功效之濃度下,亦可藉由併用該等而獲得顯著功效。又,由實施例1及比較例5可明瞭,於僅使用黃芩、桂皮及茯苓中之兩種成分之情形時完全無功效之濃度下,亦可藉由併用黃芩、桂皮及茯苓之三種成分而獲得顯著功效。 As is clear from Table 2, excellent results were obtained in the present invention, whereas satisfactory results were not obtained in the comparative examples. More specifically, from Table 2 It can be seen from Example 1 and Comparative Examples 2 to 4 that at the concentrations where Scutellaria baicalensis alone, Cinnamon bark alone, and Poria cocos alone have no effect at all, significant effects can be obtained by using them together. In addition, it is clear from Example 1 and Comparative Example 5 that in the case of using only two components of Scutellaria baicalensis, Cinnamon bark, and Poria cocos, at a concentration that is completely ineffective, the combination of three components of Scutellaria baicalensis, Cinnamon bark, and Poria cocos can also be used together. Get significant results.

又,如以下方式使用前述實施例2之液狀組成物,製造作為口腔用組成物之潔牙膏。其後,對使用感進行評價。 Moreover, using the liquid composition of the said Example 2 as follows, the toothpaste which is a composition for oral cavity was manufactured. Then, the usability was evaluated.

<配方A> <Recipe A>

首先,將前述實施例1之液狀組成物添加至特定量之作為多孔質體之沸石中。 First, the liquid composition of Example 1 was added to a specific amount of zeolite as a porous body.

其後,依據以下配方(單位:質量%),根據常法製造作為口腔用組成物之潔牙膏。 Then, according to the following formulation (unit: mass %), the toothpaste which is a composition for oral cavity was manufactured according to an ordinary method.

黃芩:0.001 Skullcap: 0.001

桂皮:0.0015 Cinnamon: 0.0015

茯苓:0.005 Poria: 0.005

碳酸鈣:30.0 Calcium carbonate: 30.0

無水矽酸:5.0 Anhydrous silicic acid: 5.0

沸石:5.0 Zeolite: 5.0

山梨糖醇液:15.0 Sorbitol liquid: 15.0

濃甘油:10.0 Concentrated glycerin: 10.0

羧甲基纖維素鈉:1.0 Sodium carboxymethylcellulose: 1.0

月桂基硫酸鈉:0.5 Sodium Lauryl Sulfate: 0.5

糖精鈉:0.05 Sodium Saccharin: 0.05

香料:1.0 Spices: 1.0

水:餘量 water: balance

<配方B> <Recipe B>

首先,將前述實施例1之液狀組成物與以下之質量%之各成分混合。其後,依據以下配方(單位:質量%),根據常法製造作為口腔用組成物之潔牙膏。 First, the liquid composition of the above-mentioned Example 1 was mixed with each component of the following mass %. Then, according to the following formulation (unit: mass %), the toothpaste which is a composition for oral cavity was manufactured according to an ordinary method.

黃芩:0.001 Skullcap: 0.001

桂皮:0.0015 Cinnamon: 0.0015

茯苓:0.005 Poria: 0.005

碳酸鈣:30.0 Calcium carbonate: 30.0

無水矽酸:5.0 Anhydrous silicic acid: 5.0

山梨糖醇液:15.0 Sorbitol liquid: 15.0

濃甘油:10.0 Concentrated glycerin: 10.0

羧甲基纖維素鈉:1.0 Sodium carboxymethylcellulose: 1.0

月桂基硫酸鈉:0.5 Sodium Lauryl Sulfate: 0.5

糖精鈉:0.05 Sodium Saccharin: 0.05

香料:1.0 Spices: 1.0

水:餘量 water: balance

亦即,配方B之潔牙膏於以下方面與配方A之潔牙膏不同:不含作為多孔質體之沸石,與此相應地水之含有率增多。 That is, the toothpaste of formula B differs from the toothpaste of formula A in that it does not contain zeolite as a porous body, and accordingly the content rate of water increases.

讓15名成人將藉由前述方式獲得之兩種潔牙膏(口腔用組成物)適量(約1g)置於市售牙刷上使用,評價使用時之使用感。 An appropriate amount (about 1 g) of the two kinds of toothpastes (oral composition) obtained in the above-mentioned manner was put on a commercially available toothbrush by 15 adults, and the feeling of use during use was evaluated.

其結果,全部15名人員均回答,配方A之潔牙膏(口腔用組成物)與配方B之潔牙膏(口腔用組成物)之使用時相比較,苦味等不快感更少。 As a result, all 15 people answered that the toothpaste (oral composition) of formulation A had less unpleasantness such as bitterness than when using the toothpaste (oral composition) of formulation B.

又,使用前述實施例及比較例之液狀組成物(含有水之組成物),依據以下配方(單位:質量%),根據常法製造作為口腔用組成物之漱口液(漱口劑)、假牙清潔劑及假牙穩定劑。 Moreover, using the liquid compositions (compositions containing water) of the aforementioned Examples and Comparative Examples, according to the following formulation (unit: mass %), a mouthwash (mouthwash) as an oral composition was produced according to a conventional method. , denture cleaners and denture stabilizers.

<漱口液> <Mouthwash>

黃芩:0.001 Skullcap: 0.001

桂皮:0.0015 Cinnamon: 0.0015

茯苓:0.005 Poria: 0.005

改性醇56號:5.0 Modified alcohol No. 56: 5.0

聚氧乙烯氫化蓖麻油:0.5 Polyoxyethylene hydrogenated castor oil: 0.5

濃甘油:5.0 Concentrated glycerin: 5.0

木糖醇:5.0 Xylitol: 5.0

氯化十六烷基吡啶:0.05 Cetylpyridinium chloride: 0.05

甘草素酸二鉀:0.05 Dipotassium glycyrrhizinate: 0.05

對羥基苯甲酸乙酯:0.05 Ethylparaben: 0.05

對羥基苯甲酸丙酯:0.05 Propylparaben: 0.05

檸檬酸:0.03 Citric acid: 0.03

檸檬酸鈉:0.12 Sodium citrate: 0.12

香料:1.0 Spices: 1.0

水:餘量 water: balance

<假牙清潔劑> <Dental cleaner>

黃芩:0.001 Skullcap: 0.001

桂皮:0.0015 Cinnamon: 0.0015

茯苓:0.005 Poria: 0.005

無水矽酸:3.0 Anhydrous silicic acid: 3.0

含水矽酸:10.0 Hydrous silicic acid: 10.0

聚乙二醇400:5.0 Macrogol 400: 5.0

濃甘油:35.0 Concentrated glycerin: 35.0

60質量%山梨糖醇液:30.0 60 mass % sorbitol liquid: 30.0

月桂基硫酸鈉:2.0 Sodium Lauryl Sulfate: 2.0

羧甲基纖維素鈉:1.5 Sodium carboxymethylcellulose: 1.5

香料:1.0 Spices: 1.0

碳酸鈉:適量 Sodium carbonate: appropriate amount

水:餘量 water: balance

<假牙穩定劑> <Dental Stabilizer>

黃芩:0.001 Skullcap: 0.001

桂皮:0.0015 Cinnamon: 0.0015

茯苓:0.005 Poria: 0.005

沸石:5.0 Zeolite: 5.0

濃甘油:30.0 Concentrated glycerin: 30.0

羧甲基纖維素鈉:3.0 Sodium carboxymethylcellulose: 3.0

聚氧乙烯氫化蓖麻油:1.0 Polyoxyethylene hydrogenated castor oil: 1.0

氯化十六烷基吡啶:0.05 Cetylpyridinium chloride: 0.05

香料:1.0 Spices: 1.0

碳酸鈉:適量 Sodium carbonate: appropriate amount

水:餘量 water: balance

對該等進行與前述相同之評價,得出與前述相同之結果。 The same evaluations as described above were carried out on these, and the same results as described above were obtained.

[產業可利用性] [Industrial Availability]

本發明之口腔用組成物之特徵在於含有黃芩、桂皮及茯苓。故而,本發明之口腔用組成物與使用單獨之生藥相比可以低藥量獲得功效,具有預防口臭功效。因此,本發明之口腔用組成物具有產業上之可利用性。 The oral composition of the present invention is characterized by containing Scutellaria baicalensis, cinnamon bark and Poria cocos. Therefore, the oral composition of the present invention can obtain the effect at a lower dosage than using the crude drug alone, and has the effect of preventing bad breath. Therefore, the oral composition of the present invention has industrial applicability.

Claims (5)

一種潔牙劑,其含有黃芩、桂皮及茯苓;前述潔牙劑中之前述黃芩之含有率為0.001質量%以上至2.0質量%以下;前述潔牙劑中之前述桂皮之含有率為0.0008質量%以上至2.0質量%以下;前述潔牙劑中之前述茯苓之含有率為0.002質量%以上至4.0質量%以下。 A dentifrice comprising Scutellaria baicalensis, cinnamon bark and Poria; the content rate of the aforementioned Scutellaria baicalensis in the aforementioned dentifrice is 0.001 mass % or more to 2.0 mass % or less; the content ratio of the aforementioned cinnamon bark in the aforementioned dentifrice agent is 0.0008 mass % More than 2.0 mass % or less; The content rate of the said Poria in the said dentifrice is 0.002 mass % or more and 4.0 mass % or less. 如請求項1所記載之潔牙劑,其中將前述潔牙劑中之前述黃芩之含有率設為XA[質量%]、將前述潔牙劑中之前述桂皮之含有率設為XB[質量%]時,滿足0.00005≦XB/XA≦20000之關係。 The dentifrice according to claim 1, wherein the content of the scutellaria baicalensis in the dentifrice is X A [mass %], and the content of the cinnamon in the dentifrice is X B [ mass %], the relationship of 0.00005≦X B /X A ≦20000 is satisfied. 如請求項1或2所記載之潔牙劑,其中將前述潔牙劑中之前述黃芩之含有率設為XA[質量%]、將前述潔牙劑中之前述茯苓之含有率設為XC[質量%]時,滿足0.000025≦XC/XA≦40000之關係。 The dentifrice according to claim 1 or 2, wherein the content rate of the Scutellaria baicalensis in the dentifrice is X A [mass %], and the content rate of the Poria cocos in the dentifrice is X In the case of C [mass %], the relationship of 0.000025≦X C /X A ≦40000 is satisfied. 如請求項1或2所記載之潔牙劑,其中將前述潔牙劑中之前述桂皮之含有率設為XB[質量%]、將前述潔牙劑中之前述茯苓之含有率設為XC[質量%]時,滿足3.3≦XC/XB≦2667之關係。 The dentifrice according to claim 1 or 2, wherein the content of the cinnamon bark in the dentifrice is X B [mass %], and the content of the Poria cocos in the dentifrice is X In the case of C [mass %], the relationship of 3.3≦X C /X B ≦2667 is satisfied. 如請求項1或2所記載之潔牙劑,其中前述潔牙劑中之前述黃芩之含有率為0.001質量%以上至0.05質量%以下;前述潔牙劑中之前述桂皮之含有率為0.0008質量%以上至0.1質量%以下;前述潔牙劑中之前述茯苓之含有率為0.002質量%以上至1.0質量%以下。 The dentifrice according to claim 1 or 2, wherein the content of the scutellaria baicalensis in the dentifrice is 0.001 mass % or more and 0.05 mass % or less; and the content ratio of the cinnamon bark in the dentifrice is 0.0008 mass % % or more and 0.1 mass % or less; the content rate of the aforementioned Poria in the aforementioned dentifrice is 0.002 mass % or more and 1.0 mass % or less.
TW105139492A 2016-06-28 2016-11-30 Dentifrices TWI750142B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016128016A JP6993077B2 (en) 2016-06-28 2016-06-28 Toothpaste
JP2016-128016 2016-06-28

Publications (2)

Publication Number Publication Date
TW201800087A TW201800087A (en) 2018-01-01
TWI750142B true TWI750142B (en) 2021-12-21

Family

ID=60786331

Family Applications (1)

Application Number Title Priority Date Filing Date
TW105139492A TWI750142B (en) 2016-06-28 2016-11-30 Dentifrices

Country Status (6)

Country Link
JP (1) JP6993077B2 (en)
CN (1) CN108025028A (en)
HK (1) HK1248131A1 (en)
SG (1) SG11201811418YA (en)
TW (1) TWI750142B (en)
WO (1) WO2018003134A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011256136A (en) * 2010-06-09 2011-12-22 Nihon Univ Collagen decomposition inhibitor
KR20120005150A (en) * 2010-07-08 2012-01-16 애경산업(주) Oral cavity composition for preventing gingivitis and periodontal disease
CN104548141A (en) * 2014-12-18 2015-04-29 山东省千佛山医院 Digestive tract contrast agent having effect of treating gastrointestinal ulcer and good smearing effect

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3159509B2 (en) * 1992-03-30 2001-04-23 サンスター株式会社 Protease inhibitor
JP6291151B2 (en) * 2011-03-31 2018-03-14 小林製薬株式会社 Oral composition
CN102698122B (en) * 2012-01-10 2013-10-16 青岛华仁技术孵化器有限公司 Traditional Chinese medicinal composition for treating paradentitis, and preparation method and administration method thereof and toothpaste
JP2015054847A (en) * 2013-09-13 2015-03-23 一丸ファルコス株式会社 Periodontal disease bacterial inhibitor

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011256136A (en) * 2010-06-09 2011-12-22 Nihon Univ Collagen decomposition inhibitor
KR20120005150A (en) * 2010-07-08 2012-01-16 애경산업(주) Oral cavity composition for preventing gingivitis and periodontal disease
CN104548141A (en) * 2014-12-18 2015-04-29 山东省千佛山医院 Digestive tract contrast agent having effect of treating gastrointestinal ulcer and good smearing effect

Also Published As

Publication number Publication date
HK1248131A1 (en) 2018-10-12
CN108025028A (en) 2018-05-11
JP2018002614A (en) 2018-01-11
TW201800087A (en) 2018-01-01
SG11201811418YA (en) 2019-01-30
WO2018003134A1 (en) 2018-01-04
JP6993077B2 (en) 2022-01-13

Similar Documents

Publication Publication Date Title
KR20120034656A (en) Composition for oral cavity
JP6425648B2 (en) Oral composition
JP5381685B2 (en) Dentifrice composition
JP5402606B2 (en) Dentifrice composition
JP2019052110A (en) Oral composition
JP2009274967A (en) Composition for oral spray and preparation for oral cavity
TWI747857B (en) Denifrices
KR20130027751A (en) Oral composition containing clove oil or eugenol
WO2018066341A1 (en) Oral composition and method for suppressing discoloration of formulation and liquid separation thereof
TWI750142B (en) Dentifrices
KR20130131395A (en) Dentifrice composition
JP2012148998A (en) Dentifrice composition
JP2011162524A (en) Undiluted liquid composition for oral cavity, and method for using the same
KR20110001472A (en) Oral care composition comprising the extract of centella asiatica and oral tissue astringent
JP4712323B2 (en) Oral composition
JP2012092042A (en) Dentifrice composition and stability improving method of berberine therein
JP5742261B2 (en) Berberine-containing dentifrice composition and method for stabilizing the same
JP2005082488A (en) Composition for oral cavity and method for masking offensive taste and smell
WO2020016926A1 (en) Nonaqueous composition for oral cavity
KR101472532B1 (en) Composition for prevention or treatment of dental caries comprising asarinin
JP2023065996A (en) Liquid composition for oral cavity
JP2023165255A (en) Oral composition
JP2023079813A (en) oral composition
JP2017214373A (en) Liquid oral composition
KR20060062412A (en) Composition for cleaning the oral cavity to improve refreshment and to relieve stimulus in oral cavity